| __timestamp | Alpine Immune Sciences, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 19586000 |
| Thursday, January 1, 2015 | 16054000 | 29135000 |
| Friday, January 1, 2016 | 23316000 | 42791000 |
| Sunday, January 1, 2017 | 10626000 | 49577000 |
| Monday, January 1, 2018 | 28970000 | 89209000 |
| Tuesday, January 1, 2019 | 35847000 | 69099000 |
| Wednesday, January 1, 2020 | 27185000 | 75961000 |
| Friday, January 1, 2021 | 58742000 | 90467000 |
| Saturday, January 1, 2022 | 70243000 | 74552000 |
| Sunday, January 1, 2023 | 80904000 | 91593000 |
Unleashing the power of data
In the competitive landscape of biopharmaceuticals, innovation is the lifeblood of progress. Over the past decade, Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc. have demonstrated a steadfast commitment to research and development (R&D). From 2014 to 2023, Alpine Immune Sciences increased its R&D spending by over 560%, reflecting a strategic focus on pioneering therapies. Meanwhile, Supernus Pharmaceuticals, with a more consistent investment trajectory, saw a 370% rise in R&D expenses, underscoring its dedication to enhancing its product pipeline. Notably, in 2023, Supernus Pharmaceuticals allocated 13% more to R&D than Alpine Immune Sciences, highlighting its robust financial commitment to innovation. This decade-long analysis reveals the dynamic strategies of these companies as they navigate the ever-evolving pharmaceutical industry, striving to bring groundbreaking treatments to market.
R&D Insights: How Zoetis Inc. and Supernus Pharmaceuticals, Inc. Allocate Funds
Comparing Innovation Spending: BeiGene, Ltd. and Alpine Immune Sciences, Inc.
R&D Insights: How Intra-Cellular Therapies, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Supernus Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and HUTCHMED (China) Limited
Research and Development Investment: Alpine Immune Sciences, Inc. vs ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs Novavax, Inc.
Analyzing R&D Budgets: Vericel Corporation vs Supernus Pharmaceuticals, Inc.